Induced Pluripotent Stem Cell (iPSC) Market Report 2026
Induced Pluripotent Stem Cell (iPSC) Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Induced Pluripotent Stem Cell (iPSC) Market Report 2026

Global Outlook – By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types), By Application (Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy), By End-User (Hospitals, Research Laboratories) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Induced Pluripotent Stem Cell (iPSC) Market Overview

• Induced Pluripotent Stem Cell (iPSC) market size has reached to $3.67 billion in 2025

• Expected to grow to $5.75 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%

• Growth Driver: Neurological Disorder Prevalence Fuels Growth Of The Induced Pluripotent Stem Cell Market

• Market Trend: Collaborative Advances In Induced Pluripotent Stem Cell (iPSC) Technology Enhancing Regenerative Medicine And Personalized Therapeutic Solutions

North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Induced Pluripotent Stem Cell (iPSC) Market?

Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as from hepatocytes, fibroblasts, keratinocytes, and neurons. This process involves introducing specific genes that induce the cell to become pluripotent, meaning it can differentiate into any cell type in the body (e.g., heart, brain, liver cells).

The main derived cell types of induced pluripotent cells are hepatocytes, fibroblasts, keratinocytes, amniotic cells, and others. Hepatocytes are the liver's primary functional cells, performing a staggering array of metabolic, endocrine, and secretory tasks. The various applications include academic research, drug development, and discovery, toxicity screening, and regenerative medicine and are used in several sectors such as hospitals, and research laboratories.

Induced Pluripotent Stem Cell (iPSC) Market Global Report 2026 Market Report bar graph

What Is The Induced Pluripotent Stem Cell (iPSC) Market Size and Share 2026?

The induced pluripotent stem cell (ipsc) market size has grown strongly in recent years. It will grow from $3.67 billion in 2025 to $4.02 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to breakthroughs in cellular reprogramming research, ethical concerns around embryonic stem cells, increased funding for stem cell research, growth of academic research collaborations, rising prevalence of chronic and degenerative diseases.

What Is The Induced Pluripotent Stem Cell (iPSC) Market Growth Forecast?

The induced pluripotent stem cell (ipsc) market size is expected to see strong growth in the next few years. It will grow to $5.75 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to expansion of regenerative medicine applications, increasing demand for personalized therapies, growing investment in cell and gene therapy, rising adoption of ipscs in neurological and cardiac research, favorable regulatory support for advanced therapies. Major trends in the forecast period include growing use of ipscs in disease modeling, increasing adoption in drug discovery and toxicity testing, expansion of patient-specific cell line development, rising focus on ethical alternatives to embryonic stem cells, advancements in reprogramming efficiency and cell stability.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation

1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

2) By Application: Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

3) By End-User: Hospitals, Research Laboratories

Subsegments:

1) By Hepatocytes: iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

2) By Fibroblasts: iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

3) By Keratinocytes: iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

4) By Amniotic Cells: iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

5) By Other Derived Cell Types: Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

What Is The Driver Of The Induced Pluripotent Stem Cell (iPSC) Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the induced pluripotent stem cell market going forward. Neurological disorder refers to a medical condition that affects the nervous system, including the brain, spinal cord, and nerves. Common neurological disorders include acute spinal cord injury, Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and more. Pluripotent stem cells offer the potential for studying disease mechanisms and drug testing, providing insights into neurological disorders' causes, and aiding in the development of regenerative therapies for conditions such as Parkinson's and Alzheimer's disease. For instance, in October 2023, according to the World Federation of Neurology (WFN), a UK-based international nonprofit neurological organization, more than 40% of the global population were living with a neurological condition, and the overall neurological disease burden was projected to nearly double by 2050. Therefore, the increasing prevalence of neurological disorders is driving the growth of the induced pluripotent stem cell market.

Key Players In The Global Induced Pluripotent Stem Cell (iPSC) Market

Major companies operating in the induced pluripotent stem cell (ipsc) market are FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart

Global Induced Pluripotent Stem Cell (iPSC) Market Trends and Insights

Major companies operating in the induced pluripotent stem cell (IPSC) market are collaborating to Advance iPSC Technology to enhance regenerative medicine applications, improve disease modeling, accelerate drug discovery, and develop personalized therapeutic solutions. Induced Pluripotent Stem Cell (iPSC) technology refers to the scientific process and methodologies used to reprogram adult somatic cells (such as skin or blood cells) back into a pluripotent state, making them capable of differentiating into any type of cell in the body. For instance, in April 2024, SCG Cell Therapy Pte Ltd, a Singapore-based biotechnology company, and the Agency for Science, Technology and Research, a Singapore-based Statutory board, launched joint laboratories aimed at advancing cellular immunotherapies. The initiative is supported by close to S$30 million, emphasizing Singapore's commitment to advancing biotechnology and healthcare solutions. The collaboration aims to develop scalable manufacturing processes for GMP-grade iPSC products, addressing the challenges of translating laboratory innovations into clinically viable therapies.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Induced Pluripotent Stem Cell (iPSC) Market?

In May 2024, Theragent Inc., a US-based biotechnology company, partnered with Pluristyx Inc. With this partnership, Theragent aims to expand its portfolio by incorporating Pluristyx's expertise in providing induced Pluripotent Stem Cell (iPSC) products. Pluristyx Inc. is a US-based biotechnology company that offers induced pluripotent stem cell (iPSC) products.

Regional Outlook

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Induced Pluripotent Stem Cell (iPSC) Market?

The induced pluripotent stem cell (IPSC) market consists of sales of induced pluripotent stem cells and related services. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Induced Pluripotent Stem Cell (iPSC) Market Report 2026?

The induced pluripotent stem cell (ipsc) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the induced pluripotent stem cell (ipsc) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Induced Pluripotent Stem Cell (iPSC) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.02 billion
Revenue Forecast In 2035 $5.75 billion
Growth Rate CAGR of 9.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Derived Cell Type, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix, CellGenix, NsGene, TiGenix, Renuron Group, Smart Cells, Genenta Science, Biocad Rf, Selvita, Mabion, Pure Biologics, OncoArendi Therapeutics, Proteon Pharmaceuticals, Parexel, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, Pluristem Therapeutics, Gamida Cell, Caladrius Biosciences, BioCanRx, CellCAN, CCRM, C3i, BioCells Argentina, Stem Cells, Royan Stem Cell Technology Co., Next BioSciences, CryoSave, BioHeart
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Induced Pluripotent Stem Cell (iPSC) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Induced Pluripotent Stem Cell (iPSC) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Induced Pluripotent Stem Cell (iPSC) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Induced Pluripotent Stem Cell (iPSC) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Use Of Ipscs In Disease Modeling

4.2.2 Increasing Adoption In Drug Discovery And Toxicity Testing

4.2.3 Expansion Of Patient-Specific Cell Line Development

4.2.4 Rising Focus On Ethical Alternatives To Embryonic Stem Cells

4.2.5 Advancements In Reprogramming Efficiency And Cell Stability

5. Induced Pluripotent Stem Cell (iPSC) Market Analysis Of End Use Industries

5.1 Research Laboratories

5.2 Academic And Research Institutes

5.3 Pharmaceutical And Biotechnology Companies

5.4 Hospitals

5.5 Contract Research Organizations

6. Induced Pluripotent Stem Cell (iPSC) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Induced Pluripotent Stem Cell (iPSC) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Induced Pluripotent Stem Cell (iPSC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Induced Pluripotent Stem Cell (iPSC) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Induced Pluripotent Stem Cell (iPSC) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Induced Pluripotent Stem Cell (iPSC) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Induced Pluripotent Stem Cell (iPSC) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Induced Pluripotent Stem Cell (iPSC) Market Segmentation

9.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cell Types

9.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Academic Research, Drug Discovery And Toxicity Studies, Regenerative Medicine, Cell And Gene Therapy

9.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Research Laboratories

9.4. Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Hepatocytes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

iPSC-Derived Liver Cells For Drug Toxicity Testing, Disease Modeling And Regenerative Therapies

9.5. Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Fibroblasts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

iPSC-Derived Skin Cells For Wound Healing And Tissue Repair, Fibroblast-Based Disease Research

9.6. Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Keratinocytes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

iPSC-Derived Skin Cells For Dermatological Research, Skin Regeneration Therapies

9.7. Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Amniotic Cells, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

iPSC-Derived Cells For Prenatal Research, Amniotic Fluid-Based Regenerative Applications

9.8. Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Other Derived Cell Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Neurons For Neurological Disease Modeling, Cardiomyocytes For Heart Disease Studies, Endothelial Cells For Vascular Research

10. Induced Pluripotent Stem Cell (iPSC) Market Regional And Country Analysis

10.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market

11.1. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Induced Pluripotent Stem Cell (iPSC) Market

12.1. China Induced Pluripotent Stem Cell (iPSC) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Induced Pluripotent Stem Cell (iPSC) Market

13.1. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Induced Pluripotent Stem Cell (iPSC) Market

14.1. Japan Induced Pluripotent Stem Cell (iPSC) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Induced Pluripotent Stem Cell (iPSC) Market

15.1. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Induced Pluripotent Stem Cell (iPSC) Market

16.1. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Induced Pluripotent Stem Cell (iPSC) Market

17.1. South Korea Induced Pluripotent Stem Cell (iPSC) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Induced Pluripotent Stem Cell (iPSC) Market

18.1. Taiwan Induced Pluripotent Stem Cell (iPSC) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Induced Pluripotent Stem Cell (iPSC) Market

19.1. South East Asia Induced Pluripotent Stem Cell (iPSC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Induced Pluripotent Stem Cell (iPSC) Market

20.1. Western Europe Induced Pluripotent Stem Cell (iPSC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Induced Pluripotent Stem Cell (iPSC) Market

21.1. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Induced Pluripotent Stem Cell (iPSC) Market

22.1. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Induced Pluripotent Stem Cell (iPSC) Market

23.1. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Induced Pluripotent Stem Cell (iPSC) Market

24.1. Italy Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Induced Pluripotent Stem Cell (iPSC) Market

25.1. Spain Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market

26.1. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Induced Pluripotent Stem Cell (iPSC) Market

27.1. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Induced Pluripotent Stem Cell (iPSC) Market

28.1. North America Induced Pluripotent Stem Cell (iPSC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Induced Pluripotent Stem Cell (iPSC) Market

29.1. USA Induced Pluripotent Stem Cell (iPSC) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Induced Pluripotent Stem Cell (iPSC) Market

30.1. Canada Induced Pluripotent Stem Cell (iPSC) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Induced Pluripotent Stem Cell (iPSC) Market

31.1. South America Induced Pluripotent Stem Cell (iPSC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Induced Pluripotent Stem Cell (iPSC) Market

32.1. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Induced Pluripotent Stem Cell (iPSC) Market

33.1. Middle East Induced Pluripotent Stem Cell (iPSC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Induced Pluripotent Stem Cell (iPSC) Market

34.1. Africa Induced Pluripotent Stem Cell (iPSC) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Induced Pluripotent Stem Cell (iPSC) Market Regulatory and Investment Landscape

36. Induced Pluripotent Stem Cell (iPSC) Market Competitive Landscape And Company Profiles

36.1. Induced Pluripotent Stem Cell (iPSC) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Induced Pluripotent Stem Cell (iPSC) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Induced Pluripotent Stem Cell (iPSC) Market Company Profiles

36.3.1. FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc) Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific, Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Takara Bio Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Astellas Pharma Inc Overview, Products and Services, Strategy and Financial Analysis

37. Induced Pluripotent Stem Cell (iPSC) Market Other Major And Innovative Companies

ViaCyte, Inc, Ncardia, REPROCELL USA, Inc, Japan Tissue Engineering Co., Ltd, Merck KGaA, Cynata Therapeutics Limited, Dainippon Sumitomo Pharma, Shenzhen Bioscience, Shanghai Cell Therapy Group, Car-T Bio, JW Therapeutics, Fosun Kite Biotechnology, Shanghai UniCar Therapy, SEED Biosciences SA, Cellerix

38. Global Induced Pluripotent Stem Cell (iPSC) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Induced Pluripotent Stem Cell (iPSC) Market

40. Induced Pluripotent Stem Cell (iPSC) Market High Potential Countries, Segments and Strategies

40.1 Induced Pluripotent Stem Cell (iPSC) Market In 2030 - Countries Offering Most New Opportunities

40.2 Induced Pluripotent Stem Cell (iPSC) Market In 2030 - Segments Offering Most New Opportunities

40.3 Induced Pluripotent Stem Cell (iPSC) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Induced Pluripotent Stem Cell (iPSC) Market, Overview Of Key Products - Product Examples
  • Table 2: Global Induced Pluripotent Stem Cell (iPSC) Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Induced Pluripotent Stem Cell (iPSC) Market, Supply Chain Analysis
  • Table 4: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Raw Material Providers
  • Table 5: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Resource Providers
  • Table 6: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Manufacturers (Suppliers)
  • Table 7: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Distributors And Channel Partners
  • Table 8: Global Induced Pluripotent Stem Cell (iPSC) Market, Key Technologies & Future Trends
  • Table 9: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Trends
  • Table 10: Global Induced Pluripotent Stem Cell (iPSC) Market, Major End Users
  • Table 11: Global Induced Pluripotent Stem Cell (iPSC) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Induced Pluripotent Stem Cell (iPSC) Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Induced Pluripotent Stem Cell (iPSC) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Induced Pluripotent Stem Cell (iPSC) Market - TAM, US$ Billion, 2025
  • Table 15: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Hepatocytes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Fibroblasts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Keratinocytes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Amniotic Cells, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Other Derived Cell Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Induced Pluripotent Stem Cell (iPSC) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Induced Pluripotent Stem Cell (iPSC) Market - Company Scoring Matrix
  • Table 99: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc) Financial Performance
  • Table 100: Thermo Fisher Scientific, Inc Financial Performance
  • Table 101: Takara Bio Inc Financial Performance
  • Table 102: Lonza Group AG Financial Performance
  • Table 103: Astellas Pharma Inc Financial Performance
  • Table 104: Global Induced Pluripotent Stem Cell (iPSC) Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Induced Pluripotent Stem Cell (iPSC) Market, Competitive Dashboard
  • Table 106: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Billion), Segmentation By Derived Cell Type, 2025 – 2030
  • Table 108: Global, Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 109: Global, Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Induced Pluripotent Stem Cell (iPSC) Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Induced Pluripotent Stem Cell (iPSC) Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Induced Pluripotent Stem Cell (iPSC) Market, Supply Chain Analysis
  • Figure 4: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Raw Material Providers
  • Figure 5: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Resource Providers
  • Figure 6: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Distributors And Channel Partners
  • Figure 8: Global Induced Pluripotent Stem Cell (iPSC) Market, Key Technologies & Future Trends
  • Figure 9: Global Induced Pluripotent Stem Cell (iPSC) Market, Major Trends
  • Figure 10: Global Induced Pluripotent Stem Cell (iPSC) Market, Major End Users
  • Figure 11: Global Induced Pluripotent Stem Cell (iPSC) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Induced Pluripotent Stem Cell (iPSC) Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Induced Pluripotent Stem Cell (iPSC) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Induced Pluripotent Stem Cell (iPSC) Market - TAM, US$ Billion, 2025
  • Figure 15: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Hepatocytes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Fibroblasts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Keratinocytes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Amniotic Cells, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Induced Pluripotent Stem Cell (iPSC) Market, Sub-Segmentation Of Other Derived Cell Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Induced Pluripotent Stem Cell (iPSC) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Induced Pluripotent Stem Cell (iPSC) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Induced Pluripotent Stem Cell (iPSC) Market - Company Scoring Matrix
  • Figure 99: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc) Financial Performance
  • Figure 100: Thermo Fisher Scientific, Inc Financial Performance
  • Figure 101: Takara Bio Inc Financial Performance
  • Figure 102: Lonza Group AG Financial Performance
  • Figure 103: Astellas Pharma Inc Financial Performance
  • Figure 104: Global Induced Pluripotent Stem Cell (iPSC) Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Induced Pluripotent Stem Cell (iPSC) Market, Competitive Dashboard
  • Figure 106: Global Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Billion), Segmentation By Derived Cell Type, 2025 – 2030
  • Figure 108: Global, Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 109: Global, Induced Pluripotent Stem Cell (iPSC) Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Frequently Asked Questions

The Induced Pluripotent Stem Cell (iPSC) market was valued at $3.67 billion in 2025, increased to $4.02 billion in 2026, and is projected to reach $5.75 billion by 2030.

The global Induced Pluripotent Stem Cell (iPSC) market is expected to grow at a CAGR of 9.3% from 2026 to 2035 to reach $5.75 billion by 2035.

Some Key Players in the Induced Pluripotent Stem Cell (iPSC) market Include, FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc), Thermo Fisher Scientific, Inc, Takara Bio Inc, Lonza Group AG, Astellas Pharma Inc, ViaCyte, Inc, Ncardia, RE

Major trend in this market includes: Collaborative Advances In Induced Pluripotent Stem Cell (iPSC) Technology Enhancing Regenerative Medicine And Personalized Therapeutic Solutions. For further insights on this market. request a sample here

North America was the largest region in the induced pluripotent stem cell (IPSC) market in 2025. Western Europe was the second largest region in the global induced pluripotent stem cell (IPSC) market share. The regions covered in the induced

Customer representative image Book your 30 minutes free consultation with our research experts